Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1973 Feb;11(2):272–278. doi: 10.1128/jvi.11.2.272-278.1973

Nonlinkage of Neurovirulence Exclusively to Viral Hemagglutinin or Neuraminidase in Genetic Recombinants of A/NWS (H0N1) Influenza Virus

V Mayer 1,1, J L Schulman 1, E D Kilbourne 1
PMCID: PMC355092  PMID: 4688703

Abstract

Genetic recombination of the neurovirulent A/NWS/cc-p (H0N1) and the non-neurovirulent A/Jap.305/57 (H2N2) influenza viruses in which hemagglutinin and neuraminidase were segregated (H0N2, H2N1) were studied for neurovirulence in mice immunosuppressed with cyclophosphamide (CPA) which permitted full expression of virulence. Both H0N2 and H2N1 recombinants replicated in the brain (in contrast to the H2N2 parent) and both produced lethal effects in CPA-treated animals. Therefore we conclude that A/NWS (H0N1) neurovirulence is not exclusively linked with either the hemagglutinin or the neuraminidase of the virus. The H0N2 and H2N1 recombinants have revealed the existence of two separate attributes of neurovirulence: (i) the capacity of virus to initiate intracerebral infection and (ii) the capacity of infection, once initiated, to produce lethal disease. These studies provide further evidence for the polygenic nature of A/NWS neurovirulence.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cole G. A., Nathanson N. Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature. 1968 Oct 26;220(5165):399–401. doi: 10.1038/220399a0. [DOI] [PubMed] [Google Scholar]
  2. FRASER K. B. Features of the MEL x NWS recombination systems in influenza A virus. IV. Increments of virulence during successive cycles of double infection with two strains of influenza A virus. Virology. 1959 Oct;9:202–214. doi: 10.1016/0042-6822(59)90115-1. [DOI] [PubMed] [Google Scholar]
  3. HIRST G. K., GOTLIEB T. The experimental production of combination forms of virus. V. Alterations in the virulence of neurotropic influenza virus as a result of mixed infection. Virology. 1955 Jul;1(2):221–235. doi: 10.1016/0042-6822(55)90018-0. [DOI] [PubMed] [Google Scholar]
  4. Hobson D., Flockton H. I., Gould E. A. The inhibitor-destroying activity of influenza A virus strains of differing neurovirulence for mice. J Gen Virol. 1968 Dec;3(3):445–448. doi: 10.1099/0022-1317-3-3-445. [DOI] [PubMed] [Google Scholar]
  5. SUGIURA A., KILBOURNE E. D. GENETIC STUDIES OF INFLUENZA VIRUSES. II. PLAQUE FORMATION BY INFLUENZA VIRUSES IN A CLONE OF A VARIANT HUMAN HETEROPLOID CELL LINE. Virology. 1965 Jul;26:478–488. doi: 10.1016/0042-6822(65)90010-3. [DOI] [PubMed] [Google Scholar]
  6. Schulman J. L., Kilbourne E. D. Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci U S A. 1969 Jun;63(2):326–333. doi: 10.1073/pnas.63.2.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sugiura A., Kilbourne E. D. Genetic studies of influenza viruses. 3. Production of plaque-type recombinants with A0 and A1 strains. Virology. 1966 May;29(1):84–91. doi: 10.1016/0042-6822(66)90198-x. [DOI] [PubMed] [Google Scholar]
  8. WERNER G. H., SCHLESINGER R. W. Morphological and quantitative comparison between infectious and non-infectious forms of influenza virus. J Exp Med. 1954 Aug 1;100(2):203–216. doi: 10.1084/jem.100.2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. WERNER G. H., SCHLESINGER R. W. Morphological and quantitative comparison between infectious and non-infectious forms of influenza virus. J Exp Med. 1954 Aug 1;100(2):203–216. doi: 10.1084/jem.100.2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES